Evidence map›Paper›PMID 42466873›Full record

ArticleBritish journal of haematology2026

Hyperglycaemia as a predictor of morbidity and mortality in patients receiving an allogeneic haematopoietic stem cell transplantation.

Marieke Tienstra, Fleur R Goemans, Kylie Keijzer, Inge V G Oteman, Carin L E Hazenberg, Jaap A van Doesum, Anne G H Niezink, Goda Choi, Gerwin A Huls, Peter R van Dijk and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marieke TienstraDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0003-3561-5358
Fleur R GoemansDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Kylie KeijzerDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Inge V G OtemanDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Carin L E HazenbergDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Jaap A van DoesumDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Anne G H NiezinkDepartment of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Goda ChoiDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Gerwin A HulsDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Peter R van DijkDepartment of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.
Hilde A M KooistraDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Tom van MeertenDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0002-5581-6950
Linde M MorsinkDepartment of Hematology, University Medical Center Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for patients with haematological malignancies; however, post-transplant complications, including infections and acute graft-versus-host disease (aGvHD), remain significant issues. Identifying modifiable risk factors is therefore critical to improve patient outcomes. This retrospective study evaluated the impact of hyperglycaemia on post-transplant outcomes in adult patients undergoing allo-HSCT at the University Medical Centre Groningen between 2018 and 2024. Hyperglycaemia was defined as a glucose level exceeding 10 mmol/L in capillary or venous samples. In total, 575 patients were included. The median age was 61 years (interquartile range [IQR]: 52-68); 64% were male, and the median body mass index (BMI) was 25.3 kg/m

Indexed as

Hematologic NeoplasmsHematopoietic Stem Cell TransplantationHyperglycemiaAgedFemaleGraft vs Host DiseaseHumansMaleMiddle AgedMorbidityPrognosisRetrospective StudiesRisk FactorsTransplantation, Homologoushyperglycaemiarisk factortransplantation

Identifiers

PMID42466873
PMCPMC13570178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.